JP2024521127A5 - - Google Patents
Info
- Publication number
- JP2024521127A5 JP2024521127A5 JP2023572110A JP2023572110A JP2024521127A5 JP 2024521127 A5 JP2024521127 A5 JP 2024521127A5 JP 2023572110 A JP2023572110 A JP 2023572110A JP 2023572110 A JP2023572110 A JP 2023572110A JP 2024521127 A5 JP2024521127 A5 JP 2024521127A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- subject
- steady
- testosterone
- daily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163190609P | 2021-05-19 | 2021-05-19 | |
| US63/190,609 | 2021-05-19 | ||
| PCT/US2022/029819 WO2022245933A1 (en) | 2021-05-19 | 2022-05-18 | Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521127A JP2024521127A (ja) | 2024-05-28 |
| JP2024521127A5 true JP2024521127A5 (https=) | 2025-05-27 |
Family
ID=84140782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572110A Pending JP2024521127A (ja) | 2021-05-19 | 2022-05-18 | テストステロン補充治療を実現するための好ましい経口ウンデカン酸テストステロン療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230398128A1 (https=) |
| EP (1) | EP4340846A4 (https=) |
| JP (1) | JP2024521127A (https=) |
| KR (1) | KR20240027602A (https=) |
| AU (2) | AU2022277557B2 (https=) |
| BR (1) | BR112023024162A2 (https=) |
| CA (1) | CA3219547A1 (https=) |
| IL (1) | IL308658A (https=) |
| MX (1) | MX2023013734A (https=) |
| WO (1) | WO2022245933A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2682111A1 (en) | 2009-12-31 | 2014-01-08 | Differential Drug Development Associates LLC | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
| ES2907284T3 (es) | 2013-03-15 | 2022-04-22 | Marius Pharmaceuticals Llc | Formulaciones de emulsión |
| US12403146B2 (en) | 2019-10-30 | 2025-09-02 | Marius Pharmaceuticals, Inc. | Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2682111A1 (en) * | 2009-12-31 | 2014-01-08 | Differential Drug Development Associates LLC | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
| US20200197412A1 (en) * | 2018-12-20 | 2020-06-25 | Clarus Therapeutics, Inc. | Methods of treating testosterone deficiency |
| US11564933B2 (en) * | 2019-04-12 | 2023-01-31 | Tolmar, Inc. | Methods of treating testosterone deficiency |
-
2022
- 2022-05-18 CA CA3219547A patent/CA3219547A1/en active Pending
- 2022-05-18 AU AU2022277557A patent/AU2022277557B2/en active Active
- 2022-05-18 IL IL308658A patent/IL308658A/en unknown
- 2022-05-18 JP JP2023572110A patent/JP2024521127A/ja active Pending
- 2022-05-18 WO PCT/US2022/029819 patent/WO2022245933A1/en not_active Ceased
- 2022-05-18 KR KR1020237043696A patent/KR20240027602A/ko active Pending
- 2022-05-18 BR BR112023024162A patent/BR112023024162A2/pt not_active Application Discontinuation
- 2022-05-18 EP EP22805390.6A patent/EP4340846A4/en active Pending
- 2022-05-18 MX MX2023013734A patent/MX2023013734A/es unknown
-
2023
- 2023-05-24 US US18/201,498 patent/US20230398128A1/en active Pending
-
2024
- 2024-10-31 AU AU2024227786A patent/AU2024227786A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024521127A5 (https=) | ||
| US6200593B1 (en) | Contraceptive method employing buccal delivery of steroidal active agents | |
| RU2020109345A (ru) | Применение мавакамтена для лечения гипертрофической кардиомиопатии | |
| JP2007533697A (ja) | グルココルチコイド救急治療用の医薬組成物 | |
| JP2008542324A (ja) | 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤 | |
| CN1394140A (zh) | 前列腺素组合物和治疗男性勃起机能障碍的方法 | |
| JP2012522816A (ja) | 改良されたグルココルチコイド療法 | |
| Al-Emadi et al. | Systemic diseases among patients with and without alveolar bone loss. | |
| TW201321003A (zh) | 左心室擴張機能改善劑 | |
| Ebinc et al. | Impact of adiponectin on left ventricular mass index in non-complicated obese subjects | |
| PT1272177E (pt) | Método e formulação para o tratamento da resistência aos antihipertensos e condições associadas. | |
| JP2006514665A5 (https=) | ||
| CN113795268B (zh) | 治疗眼疾的方法 | |
| JPH05501854A (ja) | 親油性薬剤の非侵襲性用量対効果式投与のための方法及び組成物 | |
| US12257228B2 (en) | Cardioversion methods using budiodarone | |
| WO2020077819A1 (zh) | 白头翁皂苷b4抗急性痛风性关节炎的医药用途 | |
| CN102058734A (zh) | 治疗口腔粘膜溃疡的中药贴片 | |
| Koppeschaar et al. | Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary | |
| Hunter et al. | Oral and dental problems associated with pregnancy | |
| WO2006016682A1 (ja) | 血管弾力性改善剤およびその使用 | |
| JP2002114671A (ja) | サイトカイン産生抑制剤 | |
| RU2555752C2 (ru) | Лечение вагинальной атрофии у женщин с риском сердечно-сосудистой патологии | |
| RU2784896C2 (ru) | Медицинское применение анемозида b4 против острого подагрического артрита | |
| US20240009433A1 (en) | Methods for continuous oral drug delivery | |
| JP2002114672A (ja) | Ｃ型又は非ｂ非ｃ型肝炎ウイルスによる肝機能異常の改善剤 |